Ypsomed Holding AG has sold Ypsotec AG to Callista Asset Management 32 GmbH (Callista). The transaction was completed following the approval of the relevant bodies and the fulfilment of all contractual conditions and is effective immediately.

As an entrepreneurial investor, Callista specialises in transforming industrial companies. With ten portfolio companies in the metals and automotive industries, Callista brings extensive experience and industry connections to the table. We are convinced that this transition will open up new opportunities for stability, growth and successful repositioning.  By selling Ypsotec, Ypsomed has created additional financial flexibility to accelerate its strategic growth initiatives in core areas of the business. This transaction will enable the Group to invest even more in researching, developing and marketing innovative therapeutic solutions.

According to current estimates, the transaction will have no impact on the operating performance of the remaining business units.

The sale of Ypsotec is a further step to position Ypsomed and increasing our focus for the next growth phase. We would like to thank all Ypsotec employees for their many years of service and will ensure a smooth transition,

said Simon Michel, CEO of the Ypsomed Group.

Christopher Irion, Managing Director of Callista, comments on the transaction as follows:

The acquisition of the Ypsotec Group significantly strengthens our presence in the metalworking industry and is aimed at building up the international Precision Parts Group. Ypsotec has the right prerequisites for a successful transformation and thus perfectly complements our portfolio.

The Corporate Finance Group (TCFG) acted as financial advisor to Ypsomed and CMS Zurich acted as legal advisor. Massing Werner's lawyers are assisting Callista in the transaction.